Kidney disease — all decisions

The appeal for an earlier effective date for the grant of service connection for hypertension is dismissed, and several issues related to service connection are remanded for further development.

The Board remands the claims for an initial compensable rating for chronic kidney disease, a total disability rating based on individual unemployability (TDIU), and basic eligibility to Dependents' Educational Assistance (DEA) due to pre-decisional duty to assist errors.

The Board denied service connection for right lower extremity radiculopathy, denied earlier effective dates for prostate cancer residuals and major depressive disorder, denied increased ratings for CKD, tinnitus, and hearing loss, denied a higher rating for depression, and denied an earlier effective date for prostate cancer residuals. The Board granted TDIU and an earlier effective date for chronic kidney disease.

The Board remands the claims for service connection for hypertension, chronic kidney disease, and multiple myeloma due to a failure to properly develop the record.

The Board granted service connection for degenerative disc disease of the lumbar spine, osteoarthritis of the right hip, and right renal atrophy with renal insufficiency as secondary to the Veteran's left knee disability. The Board also granted a 10 percent rating for instability of the left knee.

The Board denied service connection for obstructive sleep apnea, insomnia, diabetes mellitus, type II, a kidney disability, an eye disability, bilateral lower extremities peripheral neuropathy, and bilateral upper extremities peripheral neuropathy as there was no evidence of an in-service injury or incurrence related to these conditions. The claims for service connection for bilateral hearing loss, arthritis, hypertension, headaches, and tinnitus were remanded for further development.

The Board denied the appellant's claim for increased ratings for hypertension with kidney disease, as a matter of law.

The appeal for an increased rating for bladder cancer was dismissed due to the untimely submission of a VA Form 10182. The claims for service connection for chronic kidney disease and fatty liver disease were remanded for further development.

The Board denied service connection for kidney stones and an initial compensable rating for hemorrhoids.

The Board granted service connection for chronic kidney disease (CKD) as secondary to the Veteran's service-connected diabetes mellitus, type II.

The Board denied service connection for kidney disease, finding no current disability. The claim for hypertension was remanded for a VA medical opinion.

The Board granted service connection for right ear hearing loss, lumbosacral strain with spondylosis, and end stage renal disease status post kidney transplant. The claims for left ear hearing loss, asbestosis, and tuberculosis were remanded.

The Board remands the claims for service connection for lung nodules and kidney stones to ensure adequate medical examinations are conducted.

The Board denied the Veteran's claim for service connection for renal cell carcinoma as there is no evidence of an in-service disease or injury contributing to his condition, and no medical nexus between his current diagnosis and service.

The appeal for service connection for chronic kidney disease was dismissed as the benefit sought on appeal had been granted in full.

The Board granted service connection for other specified trauma- and stressor-related disorder as part and parcel of the Veteran's service-connected PTSD and major depressive disorder.

The Board granted service connection for hypertension and chronic kidney disease, as secondary to the Veteran's service-connected conditions.

The Board granted service connection for chronic kidney disease, finding that it was at least as likely as not due to the Veteran's use of NSAIDs to manage his service-connected bilateral foot disability.

The Board granted service connection for LLE and RLE neuropathy of the peroneal nerve, effective May 25, 2016, and a TDIU from May 25, 2016. It also granted DEA benefits and SMC based on loss of use of both feet from July 28, 2020.

The Board granted service connection for prostate cancer and type II diabetes mellitus under the PACT Act, but remanded the claim for chronic kidney disease.